Voluntary Licensing Agreements for Remdesivir

“Ferozsons Laboratories from Pakistan is amongst the five companies to produce Remdesivir for distribution in 127 countries”

Lahore (Muhammad Yasir) Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand supply of Remdesivir. The agreements allow the companies – Cipla Ltd., Ferozsons Laboratories, Hetero Labs Ltd., Jubilant Lifesciences and Mylan – to manufacture Remdesivir for distribution in 127 countries. The countries consist of nearly all low-income and lower-middle income countries, as well as several upper-middle- and high-income countries that face significant obstacles to healthcare access.

Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process for Remdesivir to enable them to scale up production more quickly. The licensees also set their own prices for the generic product they produce. The licenses are royalty-free until the World Health Organization declares the end of the Public Health Emergency of International Concern regarding COVID-19, or until a pharmaceutical product other than Remdesivir or a vaccine is approved to treat or prevent COVID-19, whichever is earlier.

The agreements permit distribution in the following countries:

Afghanistan Algeria Angola Anguilla Antigua & Barbuda Armenia Aruba Azerbaijan Bahamas, The Bangladesh Barbados Belarus Belize Benin Bermuda Bhutan Botswana British Virgin Islands Burkina Faso Burundi  Cambodia Cameroon Cape Verde Cayman Island Central Af R.Chad Comoros Congo Rep. Cook IslandsCosta Rica Cote d’Ivoire CubaCuracaoD jibouti Dominica Dominican Republic Egypt El Salvador Equatorial Guinea Eritrea Eswatini (Swaziland) Ethiopia Fiji Gabon Gambia, The Georgia  Ghana Grenada Guatemala Guinea Guinea Bis Guyana Haiti Honduras India Indonesia Jamaica Kazakhstan Kenya Kiribati Korea, Dem. People’s Rep. (North Korea) Kyrgyzstan Lao DR (Laos) Lesotho Liberia Libya Madagascar Malawi Maldives Mali Marshall Islands Mauritania Mauritius Micronesia, Fed. Sts. Moldova Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Pakistan Palau Panama Papua New Guinea Philippines Rwanda Samoa Sao Tome and Principe Senegal Seychelles Sierra Leone Sint Maarten (Dutch part) Solomon Islands Somalia South Africa South Sudan Sri Lanka St. Kitts and Nevis St. Lucia St. Vincent and the Grenadines Sudan Suriname Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad & Tobago Tunisia Turkmenistan Turks & Caicos Tuvalu Uganda Ukraine Uzbekistan Vanuatu Vietnam Zambia Zimbabwe.